Related Experiment Video
Updated: May 27, 2026

10:46
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Discriminating Relapsing-Remitting From Progressive Multiple Sclerosis Using Multidimensional Speech Biomarkers: An
Jonathan Delgado Hernández1, Moisés Betancort Montesinos1, Tatiana Romero Arias2
1Universidad de La Laguna, Spain.
Summary
Acoustic speech analysis and machine learning can non-invasively differentiate multiple sclerosis (MS) phenotypes. This accessible tool effectively identifies progressive MS, aiding clinical phenotyping.
Area of Science:
- Neurology
- Biomedical Engineering
- Data Science
Background:
- Differentiating relapsing-remitting from progressive multiple sclerosis (MS) is clinically challenging.
- Current methods often rely on complex or invasive biomarkers.
- Objective phenotyping of MS subtypes is needed.
Purpose of the Study:
- To develop a machine learning model using acoustic speech analysis for classifying MS phenotypes.
- To create a non-invasive, low-cost tool for MS phenotyping.
Main Methods:
- Collected speech recordings from 300 people with MS (PwMS).
- Extracted 44 acoustic features and used elastic net for parameter selection.
- Trained and validated six supervised machine learning classifiers, including Random Forest, on acoustic features and demographic data.
- Tested the best model on an independent clinical validation cohort (n=100).
Main Results:
- Elastic net identified nine acoustic features, age, and sex as relevant parameters.
- Acoustic-only model (excluding age and sex) showed no performance degradation.
- The Random Forest model achieved an AUC of 0.84, NPV of 0.95, and LR- of 0.15 in the validation cohort.
- The model effectively ruled out progressive MS using acoustic features alone.
Conclusions:
- Multidimensional acoustic analysis combined with machine learning provides a viable non-invasive triage tool for MS phenotyping.
- The developed model is accessible, low-cost, and validated in an independent cohort.
- This approach supports objective and efficient MS phenotyping.
